Financial Report
1 January - 31 December
Attributable to shareholders of PolyPeptide Group AG:
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| kEUR | Share capital | Share premium | Translation reserve | Treasury shares | Other capital reserves | Retained earnings | Total | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| Balance as at 1 January 2022 | 302 | 212,800 | 9,285 | -1,187 | 3,946 | 196,027 | 421,173 | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| Result for the year | 
 | 
 | 
 | 
 | 
 | 7,767 | 7,767 | 
| Remeasurement gain / (loss) on defined benefit plans, net of tax | 
 | 
 | 
 | 
 | 
 | 10,352 | 10,352 | 
| Currency exchange differences | 
 | 
 | 4,834 | 
 | 
 | 
 | 4,834 | 
| Total comprehensive income | 0 | 0 | 4,834 | 0 | 0 | 18,119 | 22,953 | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| Purchase of own shares | 
 | 
 | 
 | -13,933 | 
 | 
 | -13,933 | 
| Dividends paid | 
 | -9,671 | 
 | 
 | 
 | 
 | -9,671 | 
| Share-based payment | 
 | 
 | 
 | 
 | 1,155 | 
 | 1,155 | 
| Transfer of own shares | 
 | 
 | 
 | 1,511 | -1,511 | 
 | 0 | 
| Total transactions with owners | 0 | -9,671 | 0 | -12,422 | -356 | 0 | -22,449 | 
| Balance as at 31 December 2022 | 302 | 203,129 | 14,119 | -13,609 | 3,590 | 214,146 | 421,677 | 
1 January - 31 December
Attributable to shareholders of PolyPeptide Group AG:
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| kEUR | Share capital | Share premium | Translation reserve | Treasury shares | Other capital reserves | Retained earnings | Total | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| Balance as at 1 January 2021 | 33,000 | 2,340 | -5,616 | 0 | 0 | 147,936 | 177,660 | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| Result for the year | 
 | 
 | 
 | 
 | 
 | 47,258 | 47,258 | 
| Remeasurement gain / (loss) on defined benefit plans, net of tax | 
 | 
 | 
 | 
 | 
 | 833 | 833 | 
| Currency exchange differences | 
 | 
 | 14,901 | 
 | 
 | 
 | 14,901 | 
| Total comprehensive income | 0 | 0 | 14,901 | 0 | 0 | 48,091 | 62,992 | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| Business restructuring | -33,000 | 33,000 | 
 | 
 | 
 | 
 | 0 | 
| Incorporation of PolyPeptide Group AG | 273 | 
 | 
 | 
 | 
 | 
 | 273 | 
| Issue of new shares | 29 | 182,112 | 
 | 
 | 
 | 
 | 182,141 | 
| IPO-related costs charged to equity | 
 | -4,652 | 
 | 
 | 
 | 
 | -4,652 | 
| Purchase of own shares | 
 | 
 | 
 | -5,464 | 
 | 
 | -5,464 | 
| Share-based payment | 
 | 
 | 
 | 
 | 4,264 | 
 | 4,264 | 
| Transfer of own shares | 
 | 
 | 
 | 4,277 | -3,316 | 
 | 961 | 
| Repayment by Draupnir Holding B.V. related to IPO bonus | 
 | 
 | 
 | 
 | 2,998 | 
 | 2,998 | 
| Total transactions with owners | -32,698 | 210,460 | 0 | -1,187 | 3,946 | 0 | 180,521 | 
| Balance as at 31 December 2021 | 302 | 212,800 | 9,285 | -1,187 | 3,946 | 196,027 | 421,173 |